Apo-Acyclovir

Maklumat utama

  • Nama dagangan:
  • Apo-Acyclovir Tablet
  • Perubatan domain:
  • Manusia
  • Jenis perubatan:
  • Ubat Allopathic

Dokumen

Penyetempatan

  • Terdapat dalam:
  • Apo-Acyclovir Tablet
    Malaysia
  • Bahasa:
  • Bahasa Melayu

Maklumat lain

Status

  • Sumber:
  • NPRA - National Pharmaceutical Regulatory Agency - Bahagian Regulatori Farmasi Negara
  • Nombor kebenaran:
  • MAL19984321, MAL19984322, MAL19984323
  • Kemaskini terakhir:
  • 31-08-2017

Risalah Maklumat Pesakit: ciri produk - komposisi, petunjuk, kesan sampingan, dos, interaksi, tindak balas buruk, kehamilan, penyusuan

APO-ACYCLOVIR TABLET

Acyclovir (200mg, 400mg, 800mg)

1

Risalah Maklumat Ubat untuk Pengguna (RiMUP)

Apakah yang ada pada risalah ini

Apakah kegunaan Apo-Acyclovir

Bagaimana Apo-Acyclovirberfungsi

Sebelum menggunakan Apo-

Acyclovir

Cara menggunakan Apo-Acyclovir

Semasa menggunakan Apo-

Acyclovir

Kesan-kesan sampingan

Cara penyimpanan dan pelupusan

Apo-Acyclovir

Maklumat lanjut

Pengilang dan Pemegang

Pendaftaran Produk

Tarikh kemaskini RiMUP

Apakah kegunaan Apo-Acyclovir

Apo-Acyclovir digunakan untuk rawatan

herpes genitalis

(sejenis penyakit

jangkitan seks yang biasanya dikesan

dengan kesakitan pada tempat kemaluan)

herpes zoster

(kayap)

Bagaimana Apo-Acyclovir berfungsi

Apo-Acyclovir adalah ubat preskripsi

yang mengandungi bahan aktif,

acyclovir.

Apo-Acyclovir merupakan

agen antiviral. Ia bertindak melambatkan

pertumbuhan dan penyebaran virus

herpes

supaya badan boleh melawan

jangkitan.

Sebelum menggunakan Apo-Acyclovir

Bila tidak boleh menggunakan

Jika anda alah kepada acyclovir, atau

mana-mana bahan kandugan ubat ini.

(Sila rujuk

Maklumat Lanjut

Mengandung dan menyusukan anak

Jangan ambil Apo-Acyclovir jika anda

mengandung, sedang merancang untuk

mengandung atau mungkin

mengandung.

Jangan ambil Apo-Acyclovir jika anda

sedang menyusukan anak. Dapatkan

nasihat doktor atau ahli farmasi

sebelum mengambil sebarang ubat.

Sebelum mula mengambil

Sebelum mula mengambil Apo-

Acyclovir, doktor anda patut tahu jika

anda mempunyai sebarang keadaan

perubatan lain, termasuk penyakit hati

dan buah pinggang.

Beritahu doktor anda jika anda

mengandung atau merancang untuk

menjadi hamil sebelum mengambil

Apo-Acyclovir. Doktor anda akan

membincangkan risiko dan faedah

mengambil ubat ini dengan anda.

Jika mengambil ubat-ubat lain

Beritahu doktor jika anda

menggunakan sebarang ubat lain,

termasuk ubat yang dibeli tanpa

preskripsi dari farmasi, pasaraya, atau

kedai makanan kesihatan.

Contoh ubat yang mungkin

berinteraksi dengan Apo-Acyclovir

adalah

probenecid

, sejenis ubat yang

digunakan untuk merawat asid urik

tinggi.

Jumpa doktor atau ahli farmasi anda

untuk maklumat lanjut jika terdapat

persoalan yang anda tidak faham.

Mereka mempunyai maklumat lebih

terperinci tentang ubatan yang

mungkin akan berinteraksi dengan

Apo-Acyclovir.

Cara menggunakan Apo-Acyclovir

Berapa banyak harus digunakan

Ikut arahan doktor atau ahli farmasi

anda dengan teliti. Ia mungkin berbeza

dari maklumat di dalam risalah ini.

Jika anda tidak memahami arahan pada

label ubat anda, sila rujuk kepada

doktor atau ahli farmasi.

Herpes Genitalis

Secara umum, dos yang normal adalah

200mg 5 kali sehari (untuk diambil

setiap 4 jam) selama 10 hari. Walau

bagaimanapun, doktor anda boleh

menyelaras dos anda mengikut

keadaan penyakit seperti jangkitan

awal atau jangkitan berulang.

Herpes Zoster

800 mg bagi setiap 4 jam, 5 kali sehari

selama 7 hingga 10 hari. Rawatan

perlu dimulakan dalam tempoh 72 jam

apabila luka-luka mula menonjol.

Dalam ujian klinikal, manfaat terbesar

berlaku apabila rawatan dimulakan

dalam tempoh 48 jam bermulanya

luka-luka.

Jika anda mempunyai masalah buah

pinggang, doktor akan menyesuaikan

dos mengikut keadaan penyakit buah

pinggang anda.

Kanak-kanak

Untuk rawatan jangkitan

herpes

simplex

(kudis) dan mencegah kudis

untuk kanak-kanak yang mepunyai

kekurangan imuniti, dos untuk dewasa

akan diberikan kepada kanak-kanak 2

tahun dan ke atas. Kanak-kanak <2

tahun akan diberikan separuh dos

dewasa.

Untuk rawatan jangkitan varicella

(cacar air):

Doktor akan mengira dos anda

berdasarkan 20mg/kg berat badan 4

kali sehari untuk 5 hari.

Ikut dos yang ditetapkan oleh doktor

anda. Dos yang sesuai untuk anda

tidak semestinya sama seperti yang

dinyatakan di atas.

Bila perlu digunakan

Ikut arahan doktor atau ahli farmasi

anda.

Telan tablet ini dengan air tanpa

mengunyahnya.

Doktor anda akan memulakan terapi

untuk anda seawal mungkin

berdasarkan masa tanda-tanda dan

simptom berlaku.

Berapa lama perlu digunakan

Jangan sekali-kali menambah atau

mengurangkan jumlah dos Apo-

Acyclovir anda, melainkan jika doktor

memberitahu anda dan jangan berhenti

mengambil ubat ini tanpa berunding

dengan doktor anda terlebih dahulu.

Jika terlupa menggunakan

Rujuk kepada doktor atau ahli farmasi

anda tentang apa yang perlu dilakukan

jika anda terlupa menggunakan ubat

ini.

2

Risalah Maklumat Ubat untuk Pengguna (RiMUP)

Ambil dos yang terlepas sebaik sahaja

anda teringat. Sekiranya sudah hampir

masa untuk dos seterusnya, abaikan

dos terlepas dan tunggu untuk

mengambil dos seterusnya pada masa

biasa. Jangan ambil dos berganda

untuk menggantikan dos yang

tertinggal.

Jika mengambil berlebihan (terlebih

dos)

Hubungi doktor anda dengan segera

atau pergi ke Jabatan Kecemasan

hospital terdekat, jika terambil dos

berlebihan. Ini perlu dilakukan

walaupun tiada sebarang kesan

keracunan atau rasa tidak selesa. Anda

mungkin memerlukan perhatian

perubatan segera.

Semasa menggunakan Apo-Acyclovir

Perkara yang perlu dilakukan

Ambil ubat anda mengikut arahan

doktor.

Maklumkan kepada semua doktor,

doktor gigi dan ahli farmasi yang

merawat anda bahawa anda sedang

menggunakan Apo-Acyclovir.

Beritahu doktor anda dengan segera

jika anda menjadi hamil semasa

menggunakan ubat ini.

Perkara yang tidak boleh dilakukan

Jangan berhenti menggunakan ubat ini

kecuali diarahkan oleh doktor anda.

Jangan mula mengambil sebarang ubat

baru tanpa berbincang dengan doktor

atau ahli farmasi anda.

Jangan berkongsi Apo-Acyclovir

dengan sesiapa, walaupun mereka

mempunyai simptom atau penyakit

yang sama.

Perkara yang perlu diberi perhatian

Jika ubat ini menyebabkan anda terasa

tidak selesa, beritahu kepada doktor

anda dengan segera.

Memandu dan menggunakan jentera

Ubat ini mungkin mengganggu

keupayaan anda untuk memandu atau

mengendalikan jentera, Jika ubat ini

menyebabkan anda terasa loya, pening,

letih, atau sakit kepala, jangan

memandu atau mengendalikan jentera

dan hubungi doktor anda dengan

segera.

Kesan-kesan sampingan

Seperti ubat-ubatan lain, Apo-Acyclovir

boleh menyebabkan kesan sampingan,

walaupun bukan semua orang

mengalaminya.

Kesan sampingan dengan penggunaan

Acyclovir termasuk: Loya, muntah, sakit

kepala, dan juga yang kurang kerap

berlaku seperti cirit-birit, pening, dan

tiada selera .

Jumpa doktor atau ahli farmasi anda

dengan segera jika anda mengalami

sebarang kesan sampingan selepas

menggunakan ubat ini.

Ini bukan senarai lengkap kesan-kesan

sampingan untuk Apo-Acyclovir. Jika

anda tidak pasti, rujuk kepada doktor

atau ahli farmasi kerana mereka akan

mempunyai senarai yang lebih terperinci

dan lengkap.

Anda boleh melaporkan sebarang kesan

sampingan atau kesan advers ubat

kepada Pusat Pemantauan Kesan Advers

Ubat Kebangsaan melalui No. Tel: 03-

78835550, atau laman web

portal.bpfk.gov.my (

Consumers

Reporting

Cara penyimpanan dan pelupusan

Apo-Acyclovir

Penyimpanan

Anda diingatkan supaya menyimpan

Apo-Acyclovir dan semua ubat-ubat

lain jauh daripada kanak-kanak.

Jangan gunakan ubat ini selepas tarikh

bulan dan tahun seperti mana yang

ditulis pada EXP di bekas.

Simpan Apo-Acyclovir pada suhu 20-

25 °C di tempat kering dan dilindungi

daripada cahaya.

Pelupusan

Ubat-ubatan tidak harus dilupuskan

melalui air buangan atau sisa isi

rumah. Sila rujuk kepada ahli farmasi

anda mengenai cara yang betul untuk

melupuskan ubat yang tidak

diperlukan lagi. Langkah-langkah ini

dapat membantu melindungi alam

sekitar.

Maklumat lanjut

Rupa dan warna produk

Tablet 200mg berbentuk bulat, warna

biru dengan tepi yang serong.

Perkataan "APO" diukir di atas "200"

pada satu pemukaan dan kosong pada

permukaan yang lain.

Tablet 400mg berwarna merah jambu,

bentuk bulat, permukaan yang rata

dengen tepi yang serong. Perkataan

"APO" diukir di atas "400" pada satu

permukaan dan kosong pada

permukaan yang lain.

Tablet 800mg berbentuk bujur, warna

biru, dwi cembung, perkataan "APO"

diukir di atas "800" pada satu

permukaan dan kosong pada

permukaan yang lain.

Bahan-bahan kandungan

Bahan aktif

Acyclovir

Bahan tidak aktif

Bahan tidak aktif (200mg

):

Lactose Monohydrate NF,

Microcrystalline Cellulose,

Magnesium Stearate, Croscomellose

Dosium, Indigotine Al Lake,

Colloidal Silicon Dioxide.

Bahan Tidak Aktif (400mg):

Purified Water, Magnesium

Stearate, Croscarmellose Sodium,

Red Ferric Oxide, Collodial Silicon

Dioxide, Microcrystalline Cellulose.

Bahan tidak aktif (800mg):

Purified Water, Magnesium

Stearate, Croscarmellose Sodium,

Indigotine AL Lake, Brilliant Blue,

Colloidal Silicon Dioxide,

Microcrystalline Cellulose.

3

Risalah Maklumat Ubat untuk Pengguna (RiMUP)

Nombor MAL

Apo-Acyclovir 200mg tablet

MAL19984321AZ

Apo-Acyclovir 400mg tablet

MAL19984322AZ

Apo-Acyclovir 800mg tablet

MAL19984323AZ

Pengilang

Apotex Incorporated,

150 Signet Drive,

Weston, Ontario,

Canada M9L IT9

Pemegang Pendaftaran Produk

Pharmaforte (M) Sdn Bhd

2, Jalan PJU 3/49

Sunway Damansara

47810 Petaling Jaya

Tarikh kemaskini RiMUP

06/01/2016

Nombor Siri

BPFK(R4/1)041115/00396

21-3-2019

Safety and efficacy of Cinergy® Life B3 HiCon (Bacillus amyloliquefaciens NRRL B‐50508, B. amyloliquefaciens NRRL B‐50509 and Bacillus subtilis NRRL B‐50510) as a feed additive for pigs for fattening and minor porcine species

Safety and efficacy of Cinergy® Life B3 HiCon (Bacillus amyloliquefaciens NRRL B‐50508, B. amyloliquefaciens NRRL B‐50509 and Bacillus subtilis NRRL B‐50510) as a feed additive for pigs for fattening and minor porcine species

Published on: Wed, 20 Mar 2019 The additive contains viable spores of two strains of Bacillus amyloliquefaciens and a single strain of Bacillus subtilis and is intended to be used with pigs for fattening and minor porcine species at a minimum inclusion level of 1.5 × 108 colony forming units (CFU)/kg complete feedingstuffs. The two bacterial species are considered suitable for the qualified presumption of safety (QPS) approach to safety assessment, which requires the identity of the strains to be establ...

Europe - EFSA - European Food Safety Authority EFSA Journal

13-3-2019

Pest categorisation of Phymatotrichopsis omnivora

Pest categorisation of Phymatotrichopsis omnivora

Published on: Tue, 12 Mar 2019 The Panel on Plant Health performed a pest categorisation of Phymatotrichopsis omnivora, the causal agent of Phymatotrichum root rot of more than 2,000 dicotyledonous plant species, for the EU. The pest is listed as Trechispora brinkmannii in Annex IAI of Directive 2000/29/EC. P. omnivora is a well‐defined fungal species and reliable methods exist for its detection and identification. It is present in south‐western USA, northern Mexico, Libya and Venezuela. The pest is not...

Europe - EFSA - European Food Safety Authority EFSA Journal

7-3-2019

Pest survey card on Popillia japonica

Pest survey card on Popillia japonica

Published on: Wed, 06 Mar 2019 This pest survey card was prepared in the context of the mandate on plant pest surveillance (EFSA‐Q‐2017‐00831), upon request by the European Commission. The purpose of this document is to assist the Member States in planning annual survey activities of quarantine organisms using a statistically sound and risk‐based pest survey approach, in line with the current international standards. The data requirements for such activity include the pest distribution, its host range, ...

Europe - EFSA - European Food Safety Authority EFSA Journal

7-3-2019

Safety and efficacy of Robenz® 66G (robenidine hydrochloride) for chickens for fattening and turkeys for fattening

Safety and efficacy of Robenz® 66G (robenidine hydrochloride) for chickens for fattening and turkeys for fattening

Published on: Tue, 05 Mar 2019 Following a request from European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of Robenz® 66G (robenidine hydrochloride (HCl)) when used as a feed additive for chickens for fattening and turkeys for fattening. The coccidiostat Robenz®66G is considered safe for chickens for fattening at the highest proposed level of 36 mg robenidine HCl/kg complete feed with a ...

Europe - EFSA - European Food Safety Authority EFSA Journal

5-3-2019

Safety and efficacy of Beltherm MP/ML (endo-1,4-betaxylanase) as a feed additive for piglets, pigs for fattening and other porcine species

Safety and efficacy of Beltherm MP/ML (endo-1,4-betaxylanase) as a feed additive for piglets, pigs for fattening and other porcine species

Published on: Mon, 04 Mar 2019 Beltherm MP/ML contains endo-1,4-beta-xylanase and it is to be used as a zootechnical additive for weaned piglets, pigs for fattening and minor porcine species for fattening. The safety and efficacy of the additive when used for poultry species have been evaluated previously by the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP Panel). In that assessment, the safety for the consumers, environment and the users was assessed. The applicant has ...

Europe - EFSA - European Food Safety Authority EFSA Journal

5-3-2019

Safety and efficacy of Beltherm MP/ML (endo‐1,4‐beta‐xylanase) as a feed additive for chickens for fattening, chickens reared for laying, turkeys for fattening, turkeys reared for breeding, turkeys for breeding purposes and minor poultry species

Safety and efficacy of Beltherm MP/ML (endo‐1,4‐beta‐xylanase) as a feed additive for chickens for fattening, chickens reared for laying, turkeys for fattening, turkeys reared for breeding, turkeys for breeding purposes and minor poultry species

Published on: Fri, 01 Mar 2019 Beltherm MP/ML contains endo‐1,4‐beta‐xylanase and is intended to be used as a zootechnical additive for poultry species. The safety and efficacy of the additive have been evaluated by the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP Panel) in 2017. In that assessment, the additive and the production strain, a genetically modified strain of Bacillus subtilis, were characterised in full. No viable cells of the production strain were detecte...

Europe - EFSA - European Food Safety Authority EFSA Journal

5-3-2019

Safety and efficacy of Calsporin® (Bacillus subtilis DSM 15544) for all poultry species

Safety and efficacy of Calsporin® (Bacillus subtilis DSM 15544) for all poultry species

Published on: Fri, 01 Mar 2019 The additive Calsporin® is a preparation of viable spores of Bacillus subtilis DSM 15544, at a minimum declared concentration of 1 × 1010 colony forming units (CFU)/g additive. The additive is authorised as a zootechnical additive (functional group: gut flora stabiliser) for use in chickens for fattening, weaned piglets, chickens reared for laying, turkeys, minor avian species and other ornamental and game birds, laying hens and ornamental fish, dogs, in sows and in suckli...

Europe - EFSA - European Food Safety Authority EFSA Journal

26-2-2019

Safety and efficacy of TYFER™ (ferric tyrosine chelate) as a zootechnical feed additive for chickens, turkeys and minor poultry species for fattening or reared for laying/breading

Safety and efficacy of TYFER™ (ferric tyrosine chelate) as a zootechnical feed additive for chickens, turkeys and minor poultry species for fattening or reared for laying/breading

Published on: Mon, 25 Feb 2019 Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of the product TYFER™ (ferric tyrosine chelate) as zootechnical feed additive for chickens, turkeys and minor poultry species for fattening or reared for laying/breeding. The additive is safe for chickens for fattening at the maximum expected level of 200 mg TYFER™/kg complete feed; this conclusion can be extended to chickens reared for laying/breedin...

Europe - EFSA - European Food Safety Authority EFSA Journal

16-1-2019

Safety and efficacy of B‐Act® (Bacillus licheniformis DSM 28710) as a feed additive for turkeys for fattening, turkeys reared for breeding and minor poultry species for fattening or raised for laying

Safety and efficacy of B‐Act® (Bacillus licheniformis DSM 28710) as a feed additive for turkeys for fattening, turkeys reared for breeding and minor poultry species for fattening or raised for laying

Published on: Mon, 14 Jan 2019 Following a request from the European Commission, the EFSA Panel on Additives and Products or Substances used in Animal Feed was asked to deliver a scientific opinion on the safety and efficacy of B‐Act® when used in feed for turkeys for fattening, reared for breeding and minor poultry species for fattening or raised for laying. B‐Act® is a preparation containing viable spores of a Bacillus licheniformis strain. This species is considered by EFSA to be suitable for the qua...

Europe - EFSA - European Food Safety Authority EFSA Journal

16-1-2019

Voluntary Recall Notice of El Guapo Chile Habanero and Chile Pasilla-Ancho Pouches Due to Unlabeled Peanut Allergen

Voluntary Recall Notice of El Guapo Chile Habanero and Chile Pasilla-Ancho Pouches Due to Unlabeled Peanut Allergen

Mojave Foods Corporation is initiating a voluntary recall of El Guapo Chile Habanero and Chile Pasilla-Ancho pouches due to an unlabeled peanut allergen.

FDA - U.S. Food and Drug Administration

18-12-2018

Apo-Prednisone 5 mg Tablet (2018-12-18)

Apo-Prednisone 5 mg Tablet (2018-12-18)

Health Canada

11-12-2018

International Lubricants, Inc. recalls Kool-It Evaporator & Heater Foam Cleaner

International Lubricants, Inc. recalls Kool-It Evaporator & Heater Foam Cleaner

The recalled product does not have proper consumer chemical hazard labelling as required by the Consumer Chemicals and Containers Regulations, 2001 under the Canada Consumer Product Safety Act.

Health Canada

27-11-2018

Database of processing techniques and processing factors compatible with the EFSA food classification and description system FoodEx 2 Objective 1: Compendium of Representative Processing Techniques investigated in regulatory studies for pesticides

Database of processing techniques and processing factors compatible with the EFSA food classification and description system FoodEx 2 Objective 1: Compendium of Representative Processing Techniques investigated in regulatory studies for pesticides

Published on: Mon, 26 Nov 2018 EFSA is conducting pan‐European dietary exposure and risk assessments related to actual levels of pesticide residues in food commodities. These assessments use the pesticide occurrence data generated under the official monitoring programs of Member States, the consumption data from EFSA's comprehensive food consumption database and pesticide‐specific information such as processing factors. Currently no harmonised list of processing factors is available within Europe and wo...

Europe - EFSA - European Food Safety Authority Publications

13-11-2018

Setting of import tolerances for teflubenzuron in grapefruits, mandarins and broccoli

Setting of import tolerances for teflubenzuron in grapefruits, mandarins and broccoli

Published on: Mon, 12 Nov 2018 00:00:00 +0100 In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant BASF Agro BV submitted a request to the competent national authority in the United Kingdom to set import tolerances for the active substance teflubenzuron in grapefruits and mandarins imported from Brazil and for broccoli imported from Paraguay. The data submitted were found to be sufficient to derive maximum residue level (MRL) proposals for grapefruits and broccoli. The MRL derived ...

Europe - EFSA - European Food Safety Authority Publications

10-11-2018

Pest categorisation of Popillia japonica

Pest categorisation of Popillia japonica

Published on: Thu, 08 Nov 2018 00:00:00 +0100 The Panel on Plant Health performed a pest categorisation of Popillia japonica(Coleoptera: Scarabaeidae) for the EU. P. japonica is a distinguishable species listed in Annex IAII of Council Directive 2000/29/EC. It is native to Japan but established in the USA in the early 20th century. It spreads from New Jersey to most US states east of the Mississippi, some to the west and north into Canada. P. japonica feeds on over 700 plant species. Adults attack folia...

Europe - EFSA - European Food Safety Authority Publications

7-8-2018

Voluntary Recall Notice of El Guapo Jamaica Hibiscus Flower Pouches Due to Unlabeled Peanut Allergen

Voluntary Recall Notice of El Guapo Jamaica Hibiscus Flower Pouches Due to Unlabeled Peanut Allergen

Mojave Foods Corporation is initiating a voluntary recall of four sizes of El Guapo Jamaica Hibiscus Flower packages in flexible packaging due to an unlabeled peanut allergen

FDA - U.S. Food and Drug Administration

9-6-2018

Caito Foods, LLC Voluntarily Recalls Fresh Cut Melon Products Because of Possible Health Risk

Caito Foods, LLC Voluntarily Recalls Fresh Cut Melon Products Because of Possible Health Risk

Caito Foods is voluntarily recalling fresh cut watermelon, honeydew melon, cantaloupe and fresh-cut mixed fruit containing one of these melons, produced at the Caito Foods facility in Indianapolis, because these products have the potential to be contaminated with Salmonella.

FDA - U.S. Food and Drug Administration

4-2-2019

Stalevo (Orion Corporation)

Stalevo (Orion Corporation)

Stalevo (Active substance: Levodopa,carbidopa,entacapone) - Centralised - Yearly update - Commission Decision (2019)847 of Mon, 04 Feb 2019

Europe -DG Health and Food Safety

18-12-2018

APO-Valsartan (valsartan) tablets

APO-Valsartan (valsartan) tablets

Recall - potential contamination

Therapeutic Goods Administration - Australia

10-7-2018

Corbilta (Orion Corporation)

Corbilta (Orion Corporation)

Corbilta (Active substance: levodopa / carbidopa / entacapone) - Centralised - Renewal - Commission Decision (2018)4468 of Tue, 10 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2785/R/15

Europe -DG Health and Food Safety